CYP19A1 and breast cancer: leaves to isolate the active metabolites and test their effect on the MCF-7 breast cancer cell line as well as evaluation of their epithelial growth factor receptor (EGFRwt) kinase and aromatase (CYP19A) enzyme inhibition activity.